Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett's esophagus
- PMID: 20844891
- DOI: 10.1007/s00428-010-0972-y
Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett's esophagus
Abstract
In esophageal neoplasms, the histopathologic differentiation between Barrett's esophagus with or without intraepithelial neoplasia and adenocarcinoma is often challenging. Immunohistochemistry might help to differentiate between these lesions. The expression of CDX2, LI-cadherin, mucin 2 (MUC2), blood group 8 (BG8, Lewis(y)), claudin-2, and villin was investigated in normal gastroesophageal (n = 23) and in Barrett's (n = 17) mucosa, in low-grade (n = 12) and high-grade (n = 9) intraepithelial neoplasia (IEN) as well as in esophageal adenocarcinoma (n = 16), using immunohistochemistry. For CDX2 and LI-cadherin, the immunoreactivity score was highest in IEN while for MUC2, BG8, and villin, it dropped gradually from Barrett's via IEN to adenocarcinoma, and expression of Claudin-2 was only weak and focal in all lesions. The expression of MUC2 and LI-cadherin differed significantly between all examined lesions except between low-grade and high-grade IEN. MUC2 and LI-cadherin are useful immunohistochemical markers for the differentiation between normal glandular mucosa, Barrett's mucosa, IEN, and invasive carcinoma of the esophagus; however, none of the examined markers was helpful for the differentiation between low-grade and high-grade IEN.
Similar articles
-
Liver-intestine-cadherin is a sensitive marker of intestinal differentiation during Barrett's carcinogenesis.Dig Dis Sci. 2013 Mar;58(3):699-705. doi: 10.1007/s10620-012-2425-8. Epub 2012 Oct 4. Dig Dis Sci. 2013. PMID: 23053896 Free PMC article.
-
CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma.Int J Surg Pathol. 2010 Oct;18(5):330-7. doi: 10.1177/1066896910364228. Epub 2010 May 5. Int J Surg Pathol. 2010. PMID: 20444732
-
CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?Turk Patoloji Derg. 2012;28(3):251-8. doi: 10.5146/tjpath.2012.01132. Turk Patoloji Derg. 2012. PMID: 23011828
-
Usefulness of histopathological markers in diagnosing Barrett's intraepithelial neoplasia (dysplasia).Acta Gastroenterol Belg. 2009 Oct-Dec;72(4):425-32. Acta Gastroenterol Belg. 2009. PMID: 20163037 Review.
-
The esophageal mucosa and submucosa: immunohistology in GERD and Barrett's esophagus.Ann N Y Acad Sci. 2013 Oct;1300:144-165. doi: 10.1111/nyas.12241. Ann N Y Acad Sci. 2013. PMID: 24117640 Review.
Cited by
-
Liver-intestine-cadherin is a sensitive marker of intestinal differentiation during Barrett's carcinogenesis.Dig Dis Sci. 2013 Mar;58(3):699-705. doi: 10.1007/s10620-012-2425-8. Epub 2012 Oct 4. Dig Dis Sci. 2013. PMID: 23053896 Free PMC article.
-
Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour.Histopathology. 2015 Jan;66(2):225-33. doi: 10.1111/his.12535. Epub 2014 Oct 28. Histopathology. 2015. PMID: 25307987 Free PMC article.
-
Possible roles of LI-Cadherin in the formation and maintenance of the intestinal epithelial barrier.Tissue Barriers. 2013 Jan 1;1(1):e23815. doi: 10.4161/tisb.23815. Tissue Barriers. 2013. PMID: 24665380 Free PMC article. Review.
-
High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5.BMC Gastroenterol. 2017 Feb 17;17(1):33. doi: 10.1186/s12876-017-0590-0. BMC Gastroenterol. 2017. PMID: 28212604 Free PMC article.
-
The Role of Mucin Expression in the Diagnosis of Oesophago-Gastric Cancer: A Systematic Literature Review.Cancers (Basel). 2023 Nov 1;15(21):5252. doi: 10.3390/cancers15215252. Cancers (Basel). 2023. PMID: 37958425 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous